lomitapide mesylate
lomitapide mesylate is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including Juxtapid. Available dosage form: capsule.
Drug details
- Generic Name
- lomitapide mesylate
- Brand Names
- Juxtapid
- Application Number
- NDA203858
- Sponsor
- Pharma Packaging Solutions, LLC Dba Tjoapack LLC
- NDC Codes
- 10
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- LOMITAPIDE MESYLATE
Indications and Usage
1 INDICATIONS AND USAGE JUXTAPID is indicated as an adjunct to a low-fat diet and exercise and other low density lipoprotein cholesterol (LDL-C) therapies to reduce LDL-C in adults and pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia (HoFH). JUXTAPID is a microsomal triglyceride transfer protein inhibitor indicated as an adjunct to a low-fat diet and exercise and other low-density lipoprotein cholesterol (LDL-C) therapies, to reduce LDL-C in adult and pediatric patients aged 2 years and older with HoFH. ( 1 ).